Hansoh Pharma Competitors and Similar CompaniesClear all
Hansoh Pharma's competitors and similar companies include PPD, Catalent, Shandong Xinhua Pharmaceutical and Siegfried.
 PPD PPD (Pharmaceutical Product Development) is a company that provides drug development and laboratory solutions. |  Catalent Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products. |  Shandong Xinhua Pharmaceutical Shandong Xinhua Pharmaceutical (山东新华制药股份有限公司) is a healthcare company that produces antipyretic and analgesic drugs. |  Siegfried Siegfried Holding is a company that develops and manufactures drug substances and products. | ||
Founding Date | Founding Date 1995 | Founding Date 1985 | Founding Date 2007 | Founding Date 1943 | Founding Date 1873 |
Type | Type Public | Type Subsidiary | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Shanghai, CN HQ | Locations Wilmington, US HQ Buenos Aires, AR Melbourne, AU Brussels, BE Zaventem, BE São Paulo, BR São Paulo, BR see more | Locations Bridgewater, US HQ Buenos Aires, AR Bruxelles, BE Charleroi, BE Charleroi, BE Charleroi, BE Indaiatuba, BR see more | Locations Zibo, CN HQ | Locations Zofingen, CH HQ Nantong, CN Saint Vulbas, FR Hameln, DE Minden, DE Birżebbuġa, MT Barberà Del Vallès, ES see more |
Employees | Employees 8,989 | Employees 24,5842% decrease | Employees 12,6955% increase | Employees 7,296 | Employees 3,886 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $4.7b (FY, 2020) | Revenue (est.) $4.4b (FY, 2024) | Revenue (est.) ¥8.6b (FY, 2025) | Revenue (est.) CHF1.3b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $1.7b (FY, 2020) | Cost of goods $3.4b (FY, 2024) | Cost of goods ¥7.1b (FY, 2025) | Cost of goods CHF879.1m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $3b (FY, 2020) | Gross profit $953m (FY, 2024) | Gross profit ¥1.6b (FY, 2025) | Gross profit CHF463.5m (FY, 2025) |
Net income | Net income N/A | Net income $160.6m (FY, 2020) | Net income ($1b) (FY, 2024) | Net income ¥306.3m (FY, 2025) | Net income CHF168.4m (FY, 2025) |
Operating ⚠ | |||||
Backlog | Backlog N/A | Backlog $9.5b (Q3, 2021) | Backlog $2.5b (FY, 2023) | Backlog N/A | Backlog N/A |
Countries | Countries N/A | Countries 46 (FY, 2020) | Countries 80 (FY, 2023) | Countries N/A | Countries N/A |
For sources of this data, please see the company profile
View Company Profiles
PPD
HQ
Wilmington, US
PPD (Pharmaceutical Product Development) is a company that provides drug development and laboratory solutions.
View companyCatalent
HQ
Bridgewater, US
Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.
View companyShandong Xinhua Pharmaceutical
HQ
Zibo, CN
Employees
7,296
Shandong Xinhua Pharmaceutical (山东新华制药股份有限公司) is a healthcare company that produces antipyretic and analgesic drugs.
View companySiegfried
HQ
Zofingen, CH
Employees
3,886
Siegfried Holding is a company that develops and manufactures drug substances and products.
View company